The authors reply

Hagop M. Kantarjian; Erik Vandendries; Anjali S. Advani

doi:10.1056/NEJMc1612040

The authors reply

Hagop M. Kantarjian, Erik Vandendries, Anjali S. Advani

Leukemia

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	2100-2101
Number of pages	2
Journal	New England Journal of Medicine
Volume	375
Issue number	21
DOIs	https://doi.org/10.1056/NEJMc1612040
State	Published - Nov 24 2016

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1612040

Cite this

@article{9dddb3a2a6894678b4d614e93f19b4bd,

title = "The authors reply",

author = "Kantarjian, {Hagop M.} and Erik Vandendries and Advani, {Anjali S.}",

note = "Funding Information: Dr. Kantarjian reports having received research funding from Astex Pharmaceuticals; Dr. Vandendries, holding stock in Pfizer; and Dr. Advani, having received consulting fees and honoraria from Pfizer. Updated disclosure forms have been posted with their original article of August 25, 2016. No further potential conflict of interest relevant to this letter was reported.",

year = "2016",

month = nov,

day = "24",

doi = "10.1056/NEJMc1612040",

language = "English (US)",

volume = "375",

pages = "2100--2101",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "21",

}

TY - JOUR

T1 - The authors reply

AU - Kantarjian, Hagop M.

AU - Vandendries, Erik

AU - Advani, Anjali S.

N1 - Funding Information: Dr. Kantarjian reports having received research funding from Astex Pharmaceuticals; Dr. Vandendries, holding stock in Pfizer; and Dr. Advani, having received consulting fees and honoraria from Pfizer. Updated disclosure forms have been posted with their original article of August 25, 2016. No further potential conflict of interest relevant to this letter was reported.

PY - 2016/11/24

Y1 - 2016/11/24

UR - http://www.scopus.com/inward/record.url?scp=85002107110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002107110&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1612040

DO - 10.1056/NEJMc1612040

M3 - Letter

C2 - 27959721

AN - SCOPUS:85002107110

SN - 0028-4793

VL - 375

SP - 2100

EP - 2101

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 21

ER -

The authors reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this